Company Page - ANTARES PHARMA INC

161 Cheshire Lane	Research Report	Earnings Snapshot - Last 11/06/18
Suite 100	Fact Sheet
Minneapolis, MN 55441	Financial Statements
Phone: (763) 475-7700	Peer Comparison
	Annual Reports

J. Gonella, Chmn., R.G. Harrison, CEO, L.M. Christian, CFO
Formerly MEDI-JECT CORP (NASDAQ:MEDJ). Develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. IPO at $5.50 October 02, 1996. Raised $12.1 MM, selling 2.2 MM shares, 31% of the outstanding. Lead Manager: Rodman & Renshaw.

Historical Charts Technical Analysis

No Historical Data available for ATRS

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)

Common ATRS $3.29 $3.29 0 .0 $3.13 $3.3 1,584,124 $3.13 $3.3 165,560,401

Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121

Common Stock $544,693,719

Split, Dividend and Symbol Change Information

Date Symbol Transaction Dividend Split New Symbol

07-JUN-12 AIS Symbol Changed to ATRS

10-JUN-03 ANTR Symbol Changed to AIS

07-FEB-01 MEDJ Symbol Changed to ANTR

26-FEB-99 MEDJD Symbol Changed to MEDJ

28-JAN-99 MEDJ Symbol Changed to MEDJD

28-JAN-99 MEDJD Split 1 for 5

Date	Symbol	Transaction	Split	New Symbol
07-JUN-12	AIS	Symbol Changed to		ATRS
10-JUN-03	ANTR	Symbol Changed to		AIS
07-FEB-01	MEDJ	Symbol Changed to		ANTR
26-FEB-99	MEDJD	Symbol Changed to		MEDJ
28-JAN-99	MEDJ	Symbol Changed to		MEDJD
28-JAN-99	MEDJD	Split	1 for 5

A196

QUICK NAVIGATION			SITE SEARCH Enter Keyword:

Home Subscribe Browser Help Subscriber Services B-to-B Banks Brokerage Telco Site Map Legal Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex